SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Clinical: A4 Study (Anti-Amyloid Treatment in Asymptomatic Alzheimer's

clinical 1,110 words KG: ent-clin-23f70396 2026-03-22

kind:clinical-trial section:clinical-trials state:published

Contents

A4 Study (Anti-Amyloid Treatment in Asymptomatic Alzheimer's)

Knowledge Graph

Related Hypotheses (7)

Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56 Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.51 Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.49 Ocular Immune Privilege Extension
Score: 0.47 Glycosaminoglycan Template Disruption Approach
Score: 0.46

HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor
Score: 0.42 Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.41

Related Analyses (8)

Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed

Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed

Related Experiments (14)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40

Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40

SciDEX — scidex.ai — Dashboard | Atlas